Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 3/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.33 |
| ▸ | NPC1 | O15118 | 3/20 | 0.33 |
| ▸ | RAB9A | P51151 | 3/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9906819 | 0.86 | LMNA (0.34) | SMN1; SMN2ALDH1A1NPC1RAB9ALMNA | |
| SCHEMBL26479082 | 0.85 | HPGD (0.43) | HPGDSMN1; SMN2ALDH1A1NPC1RAB9A | |
| SCHEMBL30915198 | 0.84 | HPGD (0.43) | HPGDSMN1; SMN2ALDH1A1NPC1RAB9A | |
| SCHEMBL30621106 | 0.84 | HPGD (0.43) | HPGDSMN1; SMN2ALDH1A1NPC1RAB9A | |
| SCHEMBL29702364 | 0.84 | HPGD (0.43) | HPGDSMN1; SMN2ALDH1A1NPC1RAB9A | |
| SCHEMBL12107853 | 0.84 | HPGD (0.43) | HPGDSMN1; SMN2ALDH1A1NPC1RAB9A | |
| SCHEMBL17256399 | 0.84 | HPGD (0.43) | HPGDSMN1; SMN2ALDH1A1NPC1RAB9A | |
| SCHEMBL19725977 | 0.84 | HPGD (0.43) | HPGDSMN1; SMN2ALDH1A1NPC1RAB9A | |
| SCHEMBL31121260 | 0.84 | HPGD (0.43) | HPGDSMN1; SMN2ALDH1A1NPC1RAB9A | |
| SCHEMBL2607961 | 0.84 | HPGD (0.43) | HPGDSMN1; SMN2ALDH1A1NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024146902-A1 | METHODS OF PRODUCING HYDROGEL MICROSPHERES | ASCENDIS PHARMA A/S (DK) | 2024-07-11 | — | — | WO | disclosed |
| WO-2024146920-A1 | DRUG CONJUGATES FOR THE TREATMENT OF OCULAR DISORDERS | ASCENDIS PHARMA OPHTHALMOLOGY DIVISION A/S (DK) | 2024-07-11 | — | — | WO | disclosed |